Dramatic Responses of Recurrent Upper Urinary Tract Urothelial Carcinoma Harboring FGFR3 and TP53 Activating Mutations to Pembrolizumab in Combination with Erdafitinib: A Case Report

Ding X, Zong J, Li X, Bai X, Tan B, Sun W, Wang R, Ding Y

OncoTargets and Therapy 2021, 14:2177-2183

Published Date: 25 March 2021